Handelsbanken Fonder AB Purchases 1,083 Shares of CME Group Inc. (NASDAQ:CME)

Handelsbanken Fonder AB increased its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 0.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 126,636 shares of the financial services provider’s stock after buying an additional 1,083 shares during the period. Handelsbanken Fonder AB’s holdings in CME Group were worth $27,942,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Salomon & Ludwin LLC acquired a new position in shares of CME Group during the first quarter worth approximately $28,000. Y.D. More Investments Ltd bought a new position in CME Group during the second quarter worth $36,000. McClarren Financial Advisors Inc. raised its stake in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC boosted its holdings in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Finally, Rise Advisors LLC bought a new stake in CME Group in the 1st quarter valued at $41,000. 87.75% of the stock is owned by institutional investors.

Analyst Ratings Changes

CME has been the subject of a number of research analyst reports. Barclays upped their price objective on shares of CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Keefe, Bruyette & Woods upped their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday. Citigroup boosted their price objective on CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft raised their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $213.77.

View Our Latest Report on CME

Insider Buying and Selling at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME traded up $0.16 during trading hours on Friday, hitting $224.43. The stock had a trading volume of 1,585,768 shares, compared to its average volume of 1,959,577. The stock has a market capitalization of $80.81 billion, a price-to-earnings ratio of 25.53, a P/E/G ratio of 8.74 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company’s fifty day moving average is $212.17 and its two-hundred day moving average is $207.69. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $226.78.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.30 earnings per share. On average, analysts anticipate that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. CME Group’s dividend payout ratio is 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.